Results 271 to 280 of about 298,867 (391)

Investigation of Epstein-Barr Virus-Host Interactions during Latent and Lytic Infection

, 2014
Natasha Malik
openalex   +1 more source

Liver Transplantation Outcomes in Crigler‐Najjar Syndrome in Iran: A Single‐Center Retrospective Cohort Study Over 20 Years

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background and Aims Crigler‐Najjar Syndrome (CNS) is a rare autosomal recessive disorder caused by uridine diphosphate glucuronosyltransferase (UGT1A1) deficiency, leading to unconjugated hyperbilirubinemia. Without treatment, patients are at high risk of kernicterus and irreversible neurological damage.
Sajad Teimoury, Zahra Beyzaei, Alireza Shamsaeefar, Kurosh Kazemi, Saman Nikeghbalian, Seyed‐Ali Malekhosseini, Bita Geramizadeh   +6 more
wiley   +1 more source

The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus. [PDF]

Hum Vaccin Immunother
Akingbola A, Idahor C, Adegbesan A, Fakiyesi T, Aikulola O, Tundealao S, Mariaria P.   +6 more
europepmc   +1 more source

The Impact of Surfactant Protein‐D Gene Polymorphism on COVID‐19 Clinical Outcomes

Immunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Background COVID‐19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), presents a broad spectrum of clinical manifestations, ranging from asymptomatic cases to severe, life‐threatening respiratory complications. Pulmonary surfactant‐associated protein D (SP‐D) is a critical component of pulmonary immune defense.
Nadia Nasirzadeh Kolsari, Azarakhsh Azaran, Roya Pirmoradi, Maryam Moradi, Roohangiz Nashibi, Shahram Jalilian   +5 more
wiley   +1 more source

ITP, easy as EBV: a rare case of severe immune thrombocytopenic purpura secondary to Epstein-Barr virus. [PDF]

Blood Sci
Hanna CS, Hamouche R, Godin SL, Rufo G, Kumar S.   +4 more
europepmc   +1 more source

Characterization and Intracellular Localization of the Epstein-Barr Virus Protein BFLF2: Interactions with BFRF1 and with the Nuclear Lamina

, 2005
Roberta Gonnella, Antonella Farina, Roberta Santarelli, Salvatore Raffa, Regina Feederle, Roberto Bei, Marisa Granato, Andrea Modesti, Luigi Frati, Henri‐Jacques Delecluse, Maria Rosaria Torrisi, Antonio Angeloni, Alberto Faggioni   +12 more
openalex   +1 more source

Small Business Grants Awarded by the National Institutes of Health for Rhinologic Diseases, 1985–2024

International Forum of Allergy &Rhinology, Volume 16, Issue 5, Page 512-515, May 2026.
Jack Birkenbeuel, Mishek Thapa, Ericka L. Erickson, Graham Pingree, Kai Zhao, Zachary Soler, Rodney J. Schlosser, Vinay K. Rathi   +7 more
wiley   +1 more source

Molecular Mimicry Between Epstein‐Barr Virus and Human Herpesvirus‐6 Proteins and Central Nervous System Proteins: Implications for T and B Cell Immunogenicity in an In Silico Study

Immunity, Inflammation and Disease, Volume 14, Issue 5, May 2026.
ABSTRACT Background The Epstein‐Barr virus (EBV) and human herpesvirus 6 (HHV‐6) are frequently linked to neuropsychiatric illnesses such as multiple sclerosis, depression, and chronic fatigue syndrome/myalgic encephalomyelitis. These viruses may induce autoimmune reactions by molecular mimicry, leading to damage to self‐epitopes in the central nervous
Abbas F. Almulla, Muslimbek G. Normatov, Thitiporn Supasitthumrong, Michael Maes   +3 more
wiley   +1 more source

Association between Epstein-Barr virus capsid antigen IgA positivity and increased risk of chronic obstructive pulmonary disease: a retrospective cohort study. [PDF]

BMC Res Notes
Liao NC, Lee MC, Chai HW, Li JJ, Shen FJ, Yang SF.   +5 more
europepmc   +1 more source

Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.

, 1993
A.J. Carmichael, Xia Jin, Patrick Sissons, Leszek K. Borysiewicz   +3 more
openalex   +2 more sources